Landmark Study Affirms MolecuLight’s Efficacy in Real-Time Bacterial Detection for Improved Wound Management

June 26, 2025 -

TORONTO, CANADA – June 26, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for wound care, proudly announces the publication of a landmark systematic review by researchers at Trinity College Dublin and the Royal College of Surgeons in Ireland (RCSI). Titled “The Clinical Utility

MolecuLight® Imaging Significantly Improves Outcomes and Cuts Costs for Deep Sternal Wound Infections in Taiwan Study; Signals Expansion into Surgical Applications

June 12, 2025 -

Toronto, CANADA and Taipei, TAIWAN – June 12, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for wound care, and its Taiwanese distributor, Healtdeva Company Ltd., congratulate researchers at Shuang-Ho Hospital in Taipei, Taiwan on their publication of groundbreaking findings using MolecuLight. The

MolecuLight to Showcase Innovative Wound Imaging Platform at the Society for Vascular Surgery Vascular Annual Meeting (VAM) 2025

June 4, 2025 -

Toronto, Canada – June 4, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, is pleased to announce its participation in the Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM), taking place in New Orleans,

MolecuLight Unveils Thermal Imaging for DX™ Platform, Delivering Measurement, Bacterial & Thermal Assessment in One Device, and Showcases Clinical Evidence at SAWC Spring

April 30, 2025 -

Toronto, Canada – April 30, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, today announced the immediate availability of its new Thermal Imaging Module for the MolecuLightDX™ fluorescence imaging platform. This innovative clip-on module allows

MolecuLight and DocNow Announce Integration for Seamless Data and Image Transfer for DX Devices

April 29, 2025 -

Toronto, Canada – April 29, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, and DocNow, an innovative post-acute Electronic Health Record (EHR) platform, today announced their integration for the MolecuLightDX™ device.

This powerful collaboration will

MolecuLight Optimizes Burn Care with Advanced Bacterial Imaging at the American Burn Association 2025 Annual Meeting

April 8, 2025 -

Toronto, Canada – April 8th, 2025 – MolecuLight, a global pioneer in point-of-care fluorescence imaging for rapid bacterial detection in wounds, announces its presence at the American Burn Association (ABA) Annual Meeting in Phoenix, AZ, April 8-11. MolecuLight will showcase its innovative fluorescence imaging systems that empower

Study Links Bacterial Load to Pain in Venous Ulcers, Demonstrating Effective Reduction with MolecuLight

April 3, 2025 -

Toronto, Canada – April 3rd, 2025 – A groundbreaking study published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders has unveiled a significant relationship between bacterial load and pain in patients with venous leg ulcers (VLUs), showcasing the potential of MolecuLight’s fluorescence imaging technology to

MolecuLight Showcases Advanced Wound Care Imaging at 2025 CAMPS Meeting

February 28, 2025 -

Pittsburgh, PA – 2/28/2025 – MolecuLight Inc., the leader in point-of-care fluorescence imaging devices for wound care, is excited to announce its participation in the 2025 Cellular, Acellular, and Matrix-like Products (CAMPs) Wound Care Summit, held from February 28th to March 2nd in Fort Lauderdale, Florida. In

MolecuLight Announces Presentation of its Clinical and Surgical Benefits in Reconstructive Plastic Surgery by Dr. Michael Desvigne at the 47th Annual JAB Maui Burn & Wound Symposium

January 28, 2025 -

Toronto, CANADA – January 28th, 2025 – MolecuLight Corp., a leader in point-of-care fluorescence imaging for wound care, is excited to announce that Dr. Michael N. Desvigne, a renowned board-certified plastic surgeon and wound care clinician, will present the clinical and surgical benefits of MolecuLight’s fluorescence imaging